Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300200
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,215
Award facts
- Contract value 100% obligated
- $5,215.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call award from the Office of the Director (a civilian agency) on June 25, 2012, for the procurement of drugs and biologicals. The contract, valued at $5,215.20, was performed in Bethesda, Maryland and completed by February 28, 2013. No set-aside designation was applied to this award. Pierce Biotechnology, as a child entity of the larger Thermo Electron Corporation, leveraged its parent company's established expertise in scientific instrumentation and reagent supply to fulfill this requirement.
This award represents a task order placement under an existing BPA vehicle, consistent with Thermo Electron Corporation's broader federal contracting portfolio. The parent company has maintained significant indefinite delivery vehicles with multiple federal agencies, including a $9.5 million blanket purchase agreement with the Food and Drug Administration and ongoing contracts with the Naval Sea Systems Command. Thermo Electron and its subsidiaries have established themselves as key suppliers to the Department of Health and Human Services, Department of Defense, and other agencies, providing specialized laboratory equipment, reagents, and related products to support research, public health, and regulatory initiatives.
Quick answers
Who was awarded contract HHSN26300200?
HHSN26300200 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on June 25, 2012.
How much is contract HHSN26300200 worth?
The government has obligated $5,215 on HHSN26300200.
Is contract HHSN26300200 an order under another contract?
Yes. HHSN26300200 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300200 competed?
The extent of competition for HHSN26300200 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award